G-5758 is a selective and orally effective IRE1alpha inhibitor with an IC50 of 38 nM (detected by the XBP1s luciferase reporter cell assay). G-5758 is still well tolerated in rats at oral doses up to 500 mg/kg. G-5758 can be used in the research of multiple myeloma[1].
Molecular Weight:
588.58
Purity:
98.91
CAS Number:
[2413455-99-7]
Formula:
C27H24F4N6O3S
Target:
IRE1
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
